SS Innovations International (SSII) Non Operating Income (2016 - 2026)
SS Innovations International's (SSII) quarterly Non Operating Income came in at $207538.0 in Q1 2026, down 13.71% year-on-year from $240500.0 in Q1 2025, and up 158.01% quarter-over-quarter from -$357769.0 in Q4 2025.
SS Innovations International (SSII) Non Operating Income (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Non Operating Income across 11 years of filings, most recently posting $207538.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $207538.0, down 13.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$185841.0 (down 348.79% YoY), and the FY2025 annual result was -$512825.0, down 192.65% from the prior year.
- Non Operating Income came in at $207538.0 for Q1 2026 at SS Innovations International, up from -$357769.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $240500.0 in Q1 2025 to a low of -$456812.0 in Q4 2023.
- The 5-year median for Non Operating Income is -$26971.0 (2022), against an average of -$50223.1.
- Across the five-year window, Non Operating Income sank 71076.32% in 2022 and jumped 40708.57% in 2023, its largest moves.
- SS Innovations International's Non Operating Income stood at $114336.0 in 2022, then tumbled by 499.53% to -$456812.0 in 2023, then jumped by 81.46% to -$84705.0 in 2024, then plunged by 322.37% to -$357769.0 in 2025, then soared by 158.01% to $207538.0 in 2026.
- The last three Non Operating Income figures came in at $207538.0 (Q1 2026), -$357769.0 (Q4 2025), and -$35634.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | 207,538.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207,538.00 |
| Dec 31, 2025 | -357,769.00 |
| Sep 30, 2025 | -35,634.00 |
| Jun 30, 2025 | 24.00 |
| Mar 31, 2025 | 240,500.00 |
| Dec 31, 2024 | -84,705.00 |
| Sep 30, 2024 | -40,715.00 |
| Jun 30, 2024 | -40,381.00 |
| Mar 31, 2024 | -9,434.00 |
| Dec 31, 2023 | -456,812.00 |
| Sep 30, 2023 | -46,438.00 |
| Jun 30, 2023 | -333,353.00 |
| Mar 31, 2023 | 14,283.00 |
| Dec 31, 2022 | 114,336.00 |
| Sep 30, 2022 | 1,704.00 |
| Jun 30, 2022 | -26,971.00 |
| Mar 31, 2022 | 35.00 |
| Dec 31, 2021 | -77,363.00 |
| Sep 30, 2021 | 29.00 |
| Jun 30, 2021 | 38.00 |